AnaptysBio
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $76,320 | $22,263 | $27,771 | $43,113 |
Gross Profit | 44,913 | -15,561 | -13,409 | 524 |
EBITDA | 38,238 | -18,384 | -20,618 | -3,806 |
EBIT | 37,628 | -18,985 | -21,224 | -4,407 |
Net Income | 15,113 | -38,630 | -39,329 | -21,784 |
Net Change In Cash | 76,320 | 22,263 | 27,771 | 43,113 |
Free Cash Flow | -27,368 | -40,283 | -10,735 | -66,935 |
Cash | 109,833 | 44,298 | 98,637 | 123,080 |
Basic Shares | 29,018 | 28,810 | 30,644 | 30,448 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $91,280 | $17,157 | $10,287 | $63,175 |
Gross Profit | -72,560 | -115,126 | -78,511 | -35,321 |
EBITDA | -92,744 | -156,420 | -105,257 | -55,706 |
EBIT | -95,141 | -157,072 | -107,592 | -57,795 |
Net Income | -145,231 | -163,619 | -128,723 | -57,796 |
Net Change In Cash | 91,280 | 17,157 | 10,287 | 63,175 |
Cost of Revenue | -424,421 | 245,213 | ||
Free Cash Flow | -135,695 | -121,607 | -73,951 | -47,286 |
Cash | 123,080 | 35,965 | 71,308 | 495,729 |
Basic Shares | 28,382 | 26,924 | 28,165 | 27,431 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.52 |
2025-06-30 | -$1.34 |
2025-03-31 | -$1.28 |
